Proven commercial leader with 34 years of experience in biopharma and medtech, known for helping companies solve complex commercial challenges, scale revenue, and win in competitive markets. His expertise spans market access, go-to-market execution, enterprise account strategy, and building operating models that perform under pressure.

Matthew was a founding U.S. leader of Organon following its 2020 spin-off from Merck, where he helped build and lead the U.S. Biosimilars Business Unit. He later transitioned to lead the U.S. Market Access team, overseeing Group Purchasing Organizations, National Health Systems, Federal/DoD channels, and U.S. distribution partners.

Across his career, Matthew has earned a reputation as the leader you deploy when the stakes are high and the path is unclear. He builds trust quickly, forges strong cross-functional partnerships, and inspires teams to deliver exceptional results.

In 2026, Matthew launched a new venture as a founding leader of GTM, an organization designed to connect founders and early-stage companies with seasoned subject-matter experts who can provide targeted, short-term support to accelerate growth. He is assembling a curated network of Strategic Advisors across key sectors—professionals who can be matched and deployed into critical moments where companies need exactly the right expertise to reach their next milestone.

Discover how Matthew and his team can help your business move faster and further.